Challenges in the Use of DNA Repair Deficiency As a Biomarker in Breast Cancer

Philip C. Schouten*, Sabine C. Linn

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)1867-1869
Number of pages5
JournalJournal of Clinical Oncology
Volume33
Issue number17
DOIs
Publication statusPublished - 10 Jun 2015

Keywords

  • CLINICAL-TRIAL DESIGNS
  • HOMOLOGOUS RECOMBINATION
  • PREDICTIVE BIOMARKER
  • NEOADJUVANT THERAPY
  • HIGH-RISK
  • PHASE-II
  • CHEMOTHERAPY
  • CARBOPLATIN
  • VALIDATION
  • BRCANESS

Cite this